PL BioScience GmbH announced a significant expansion of company headquarters and future manufacturing capabilities to meet the rapidly growing global demand for safe, animal-free cell culture supplements.
Located in Aachen, the new headquarters offer more than 1,200 m² of usable space, with dedicated production and storage areas alongside office space to accommodate the company’s continued growth. The expansion will enable the company to produce up to 20,000L of GMP-grade HPL per year, positioning it as the largest provider of HPL products worldwide. It will also provide more highly skilled jobs in the region.
This large in-house production capacity makes PL BioScience the first company in the HPL industry with a two-source, GMP-grade strategy when combined with the current production hub. Securing a reliable supply of HPL while strengthening the resilience of its manufacturing operations positions PL BioScience as a leading source of this essential ingredient for cell culture, including the production of life-saving cell therapies.
“This is a major step forward for PL BioScience,” said Dr. Hatim Hemeda, CEO of the German biotech. “With the new headquarters, we are accelerating our growth and strengthening our future production capabilities in response to growing global demand for HPL products. In addition, this expansion marks a significant step toward accelerating product innovation, including the further development of our new artificial HPL, the world’s first scalable, fully lab-made HPL solution.”
The facility will serve as a hub for research and product innovation, supporting the development of next-generation HPL-based media, such as artificial HPL. This recent innovation by PL BioScience is HPL produced from artificial platelets via a proprietary process, which can be developed into a nearly unlimited supply of a superior cell culture supplement. Other advanced products are in development, including specialized products tailored to the needs of different cell manufacturing applications, such as CAR-T cell manufacturing.